It is recommended that authors read the "fine print" on the publisher site very carefully before submission as each agreement covers different types of articles and has different requirements for authors.
Description | Publication fees are waived except for drug evaluation articles and content/research sponsored or funded by pharma/biotech |
Available to | Corresponding authors or co-authors with a current, full time Georgetown University Medical Center affiliation |
Journals |
Bioanalysis Future Medicinal Chemistry Pharmaceutical Patent Analyst Therapeutic Delivery Biomarkers in Medicine Epigenomics Future Cardiology Future Microbiology Future Oncology Future Virology Immunotherapy Journal of 3D Printing in Medicine Journal of Comparative Effectiveness Research Nanomedicine Neurodegenerative Disease Management Pain Management Personalized Medicine Pharmacogenomics Regenerative Medicine BioTechniques Future Drug Discovery Future Science International Journal of Pharmacokinetics Breast Cancer Management CNS Oncology Colorectal Cancer Concussion Future Neurology Future Rare Diseases Hepatic Oncology International Journal of Endocrine Oncology International Journal of Hematologic Oncology Lung Cancer Management Melanoma Management |
Copyright Details | Articles from member institutions will be published using a CC-BY-NC-ND license, unless otherwise stated in the agreement |
Institutional Repository | Authors are encouraged to ask the publisher if their article is eligible to be added into an institutional repository. If so, please contact dmlresources@georgetown.edu and a DML staff member will facilitate access into the DigitalGeorgetown institutional repository. |
Submission Guidelines |
Future Medicine author guidelines Future Science author guidelines Authors that participate are asked to include the acknowledgement statement: funding support is in part from Georgetown University Medical Center. |
Is there a code needed to receive the APC support? | NO - GUMC Corresponding authors should follow the submission guidelines linked above. |